BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 16550038)

  • 1. Update on viral hepatitis: 2005.
    Wong SN; Lok AS
    Curr Opin Gastroenterol; 2006 May; 22(3):241-7. PubMed ID: 16550038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on viral hepatitis: 2007.
    Degertekin B; Lok AS
    Curr Opin Gastroenterol; 2008 May; 24(3):306-11. PubMed ID: 18408458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on viral hepatitis: 2008.
    Degertekin B; Lok AS
    Curr Opin Gastroenterol; 2009 May; 25(3):180-5. PubMed ID: 19387254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on viral hepatitis: 2006.
    Tan J; Lok AS
    Curr Opin Gastroenterol; 2007 May; 23(3):263-7. PubMed ID: 17414841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of chronic hepatitis B virus infection - Dutch national guidelines.
    Buster EH; van Erpecum KJ; Schalm SW; Zaaijer HL; Brouwer JT; Gelderblom HC; de Knegt RJ; Minke Bakker C; Reesink HW; Janssen HL;
    Neth J Med; 2008; 66(7):292-306. PubMed ID: 18663260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic hepatitis B: a wider range of therapeutic options.
    Prescrire Int; 2007 Aug; 16(90):157-62. PubMed ID: 17724844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of viral hepatitis].
    Rambusch EG; Manns MP
    Ther Umsch; 1998 Feb; 55(2):71-6, 78-9. PubMed ID: 9545847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C: a nationwide, multicentre study in Taiwan.
    Yu ML; Lin SM; Chuang WL; Dai CY; Wang JH; Lu SN; Sheen IS; Chang WY; Lee CM; Liaw YF
    Antivir Ther; 2006; 11(8):985-94. PubMed ID: 17302368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Entecavir for the treatment of chronic hepatitis B virus infection.
    Matthews SJ
    Clin Ther; 2006 Feb; 28(2):184-203. PubMed ID: 16678641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic hepatitis B: preventing, detecting, and managing viral resistance.
    Keeffe EB; Dieterich DT; Pawlotsky JM; Benhamou Y
    Clin Gastroenterol Hepatol; 2008 Mar; 6(3):268-74. PubMed ID: 18328434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lamivudine monotherapy in HBeAg-negative chronic hepatitis B: prediction of response-breakthrough and long-term clinical outcome.
    Manolakopoulos S; Bethanis S; Elefsiniotis J; Karatapanis S; Triantos C; Sourvinos G; Touloumi G; Economou M; Vlachogiannakos J; Spandidos D; Avgerinos A; Tzourmakliotis D
    Aliment Pharmacol Ther; 2006 Mar; 23(6):787-95. PubMed ID: 16556181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection of an entecavir-resistant mutant despite prolonged hepatitis B virus DNA suppression, in a chronic hepatitis B patient with preexistent lamivudine resistance: successful rescue therapy with tenofovir.
    Leemans WF; Niesters HG; van der Eijk AA; Janssen HL; Schalm SW; de Man RA
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):773-7. PubMed ID: 18617782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of combination therapy with interferon-alpha and ribavirin for chronic hepatitis C in relation to liver fibrosis and serum aminotransferase activity].
    Karpińska E; Wawrzynowicz-Syczewska M; Jurczyk K; Morańska I; Urbanowicz W; Boroń-Kaczmarska A
    Wiad Lek; 2005; 58(11-12):616-21. PubMed ID: 16594470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of viral hepatitis].
    Vucelić B
    Acta Med Croatica; 2003; 57(3):171-81. PubMed ID: 14582463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and personalized management of hepatitis B including significance of genotypes.
    Wong VW; Sung JJ
    Curr Opin Infect Dis; 2012 Oct; 25(5):570-7. PubMed ID: 22903232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of HIV/hepatitis C virus-coinfected patient non-responders to hepatitis C virus antiviral therapy and relapsers.
    Tural C; Planas R; Sirera G; Clotet B
    Curr Opin HIV AIDS; 2007 Nov; 2(6):496-502. PubMed ID: 19372933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognosis and treatment of chronic viral hepatitis].
    Klotz F; Debonne JM
    Med Trop (Mars); 1991; 51(1):15-28. PubMed ID: 1712889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis and therapy of chronic viral hepatitis].
    Heintges T; Niederau C; Mohr L; Hensel F; Häussinger D
    Z Gastroenterol; 1996 Jul; 34(7):446-56. PubMed ID: 8928540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy of chronic viral hepatitis.
    Goeser T; Theilmann L
    Int J Clin Pharmacol Ther; 1994 Nov; 32(11):571-6. PubMed ID: 7533038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral hepatitis and antiretroviral drug interactions.
    Perronne C
    J Hepatol; 2006; 44(1 Suppl):S119-25. PubMed ID: 16360231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.